← All stories
Markets
Pentwater Capital Management Falls Below 3% Ownership in Faron Pharmaceuticals (FARN)
Faron Pharmaceuticals Ltd (FARN), the Finnish clinical-stage biopharmaceutical firm, has revealed that US-based investment manager Pentwater Capital Management LP has dropped below the 3% major shareholding threshold. The notification, subm…
Covered by 1 outlet
All coverage · 1 article